New findings reveal sotagliflozin's benefits for patients with heart failure with preserved ejection fraction without diabetes, said Juan Badimon, PhD.
Juan Badimon, PhD, FACC, FAHA
Advertisement
Juan Badimon, PhD, FACC, FAHA, is a professor of medicine and the director of the Atherothrombosis Research Unit at The Mount Sinai School of Medicine’s Cardiovascular Institute.
Articles by Juan Badimon, PhD, FACC, FAHA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD
2
Eosinophilia Linked With Immune-Related Adverse Events in NSCLC Treatment
3
POLY-HF: Polypill Boosts Heart Function, Adherence in Heart Failure
4
Bridging the Gap Between Cutting-Edge Cancer Care and Equitable Access
5
